BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23516647)

  • 1. Changes in gene expression of pial vessels of the blood brain barrier during murine neurocysticercosis.
    Mishra PK; Teale JM
    PLoS Negl Trop Dis; 2013; 7(3):e2099. PubMed ID: 23516647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis of the ependymal barrier during murine neurocysticercosis.
    Mishra PK; Teale JM
    J Neuroinflammation; 2012 Jun; 9():141. PubMed ID: 22731103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature.
    Alvarez JI; Teale JM
    Brain Res; 2007 Sep; 1169():98-111. PubMed ID: 17686468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC.
    Alvarez JI; Teale JM
    J Neuroimmunol; 2006 Apr; 173(1-2):45-55. PubMed ID: 16406118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis.
    Alvarez JI; Teale JM
    J Neuroimmunol; 2007 Jul; 187(1-2):102-13. PubMed ID: 17597230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis.
    Mishra BB; Gundra UM; Teale JM
    J Neuroinflammation; 2008 Dec; 5():53. PubMed ID: 19077284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier disruption and angiogenesis in a rat model for neurocysticercosis.
    Carmen-Orozco RP; Dávila-Villacorta DG; Cauna Y; Bernal-Teran EG; Bitterfeld L; Sutherland GL; Chile N; Céliz RH; Ferrufino-Schmidt MC; Gavídia CM; Sterling CR; García HH; Gilman RH; Verástegui MR
    J Neurosci Res; 2019 Feb; 97(2):137-148. PubMed ID: 30315659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesocestoides corti intracranial infection as a murine model for neurocysticercosis.
    Alvarez JI; Mishra BB; Gundra UM; Mishra PK; Teale JM
    Parasitology; 2010 Mar; 137(3):359-72. PubMed ID: 20109250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis.
    Mishra PK; Morris EG; Garcia JA; Cardona AE; Teale JM
    Infect Immun; 2013 Apr; 81(4):1052-63. PubMed ID: 23319563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis.
    Mishra BB; Gundra UM; Wong K; Teale JM
    Infect Immun; 2009 Dec; 77(12):5369-79. PubMed ID: 19786565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Leukocyte Infiltration in Absence of Eosinophils Correlates with Decreased Tissue Damage and Disease Susceptibility in ΔdblGATA Mice during Murine Neurocysticercosis.
    Mishra PK; Li Q; Munoz LE; Mares CA; Morris EG; Teale JM; Cardona AE
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004787. PubMed ID: 27332553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response.
    Cardona AE; Gonzalez PA; Teale JM
    Infect Immun; 2003 May; 71(5):2634-42. PubMed ID: 12704138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis.
    Gundra UM; Mishra BB; Wong K; Teale JM
    Infect Immun; 2011 Jul; 79(7):2586-96. PubMed ID: 21482681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental murine model of neurocysticercosis: first report of cerebellum as a location for Mesocestoides corti tetrathyridia.
    Fabbri J; Elissondo MC
    J Helminthol; 2019 Sep; 93(5):640-642. PubMed ID: 30064529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies.
    Alvarez JI; Rivera J; Teale JM
    PLoS Negl Trop Dis; 2008 Apr; 2(4):e218. PubMed ID: 18398489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.
    Alvarez JI; Teale JM
    Brain Res; 2008 Jun; 1214():145-58. PubMed ID: 18466882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells.
    Cardona AE; Restrepo BI; Jaramillo JM; Teale JM
    J Immunol; 1999 Jan; 162(2):995-1002. PubMed ID: 9916725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis.
    Cardona AE; Teale JM
    J Immunol; 2002 Sep; 169(6):3163-71. PubMed ID: 12218134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS.
    Haqqani AS; Nesic M; Preston E; Baumann E; Kelly J; Stanimirovic D
    FASEB J; 2005 Nov; 19(13):1809-21. PubMed ID: 16260651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
    Mishra BB; Mishra PK; Teale JM
    J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.